462 related articles for article (PubMed ID: 21586363)
1. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.
Deaglio S; Robson SC
Adv Pharmacol; 2011; 61():301-32. PubMed ID: 21586363
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signaling in liver disease.
Vaughn BP; Robson SC; Longhi MS
Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling during intestinal inflammation.
Longhi MS; Moss A; Jiang ZG; Robson SC
J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
Zhong EH; Ledderose C; De Andrade Mello P; Enjyoji K; Lunderberg JM; Junger W; Robson SC
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C15-C29. PubMed ID: 33052071
[TBL] [Abstract][Full Text] [Related]
5. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
6. History of ectonucleotidases and their role in purinergic signaling.
Zimmermann H
Biochem Pharmacol; 2021 May; 187():114322. PubMed ID: 33161020
[TBL] [Abstract][Full Text] [Related]
7. Uncaria tomentosa extract alters the catabolism of adenine nucleotides and expression of ecto-5'-nucleotidase/CD73 and P2X7 and A1 receptors in the MDA-MB-231 cell line.
Santos KF; Gutierres JM; Pillat MM; Rissi VB; Santos Araújo MD; Bertol G; Gonçalves PB; Schetinger MR; Morsch VM
J Ethnopharmacol; 2016 Dec; 194():108-116. PubMed ID: 27590731
[TBL] [Abstract][Full Text] [Related]
8. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
9. Ectonucleotidases in Intestinal and Hepatic Inflammation.
Vuerich M; Robson SC; Longhi MS
Front Immunol; 2019; 10():507. PubMed ID: 30941139
[TBL] [Abstract][Full Text] [Related]
10. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
11. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
12. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.
Beldi G; Enjyoji K; Wu Y; Miller L; Banz Y; Sun X; Robson SC
Front Biosci; 2008 Jan; 13():2588-603. PubMed ID: 17981736
[TBL] [Abstract][Full Text] [Related]
13. CD39 and control of cellular immune responses.
Dwyer KM; Deaglio S; Gao W; Friedman D; Strom TB; Robson SC
Purinergic Signal; 2007 Mar; 3(1-2):171-80. PubMed ID: 18404431
[TBL] [Abstract][Full Text] [Related]
14. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract][Full Text] [Related]
15. Human platelets express functional ectonucleotidases that restrict platelet activation signaling.
Chaurasia SN; Kushwaha G; Pandey A; Dash D
Biochem Biophys Res Commun; 2020 Jun; 527(1):104-109. PubMed ID: 32446352
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling on leukocytes infiltrating the LPS-injured lung.
Friebe D; Yang T; Schmidt T; Borg N; Steckel B; Ding Z; Schrader J
PLoS One; 2014; 9(4):e95382. PubMed ID: 24748324
[TBL] [Abstract][Full Text] [Related]
17. Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now.
Zimmermann H
Purinergic Signal; 2021 Mar; 17(1):117-125. PubMed ID: 33336318
[TBL] [Abstract][Full Text] [Related]
18. Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut.
Longhi MS; Feng L; Robson SC
Biochem Pharmacol; 2021 May; 187():114417. PubMed ID: 33460629
[TBL] [Abstract][Full Text] [Related]
19. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
20. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]